| Cat.No. | Name | Information |
|---|---|---|
| M58984 | Glembatumumab vedotin | Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate (ADC) comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB (GPNMB) and conjugated to the potent tubulinbinding cytotoxic agent MMAE via a protease-sensitive vc linker. Glembatumumab vedotin has potent anticancer effects. |
| M58983 | Denintuzumab-MMAF | Denintuzumab-MMAF is an antibody-drug conjugate (ADC). Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). Denintuzumab (hBU 12) is a recombinant humanized anti-CD19 monoclonal antibody. Denintuzumab binds to CD19 on the surface of B cells. |
| M58982 | Enapotamab vedotin | Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC). |
| M58980 | ART26.12 | ART26.12 is a potent, selective, orally active inhibitor of Fatty Acid Binding Protein 5 (FABP5). ART26.12 regulates lipid metabolism and activates cannabinoid receptors to alleviate oxaliplatin-induced pain. |
| M58979 | Recombinant Human DPP-4/CD26 Protein (HEK293, N-hFc) | Dipeptidyl peptidase-4 (DPP4) is a serine exopeptidase belonging to the S9B protein family. The enzyme is a type II transmembrane glycoprotein, expressed on the surface of many cell types. It is also present in serum and other body fluids in a truncated form (sCD26/DPPIV). As both a regulatory enzyme and a signalling factor, DPP4 has been evaluated and described in many studies. DPP4 inhibition results in increased blood concentration of the incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP). |
| M58977 | Isolithocholic acid | Isolithocholic acid (β-Lithocholic acid) is an isomer of Lithocholic acid. Isolithocholic acid, a bile acid, is formed by microbial metabolism of Lithocholic acid or Lithocholic acid 3α-sulfate. |
| M58974 | Codrituzumab-MMAE (CHO) | Codrituzumab-MMAE is an antibody-drug conjugate (ADC). Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3). |
| M58973 | FITC Palmitate | FITC-Palmitate is a fluorescently labelled fatty acid derivative made by chemically coupling fluorescein isothiocyanate (FITC) with a long chain fatty acid, palmitic acid. Due to its combination of fat solubility and green fluorescent signals, it has a variety of uses in biomedical and cell biology experiments. |
| M58972 | Agarose (high strength) | Agarose is a kind of polysaccharide that can be derived from seaweed, modified with hydroxyethyl and methoxy groups on the polysaccharide chain, which is suitable for in-gel enzymatic reactions, tissue culture, cell cloning and viral vacuole analysis and other related studies. It is commonly used in molecular biology and biochemistry to isolate and purify DNA and RNA fragments. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
